Histopathological Evaluation of Somatostatin Receptor 2 Expression in Myocarditis-Rationale for the Diagnostic Use of Somatostatin Receptor Imaging.

Autor: Polte CL; Department of Clinical Physiology, Sahlgrenska University Hospital, 41345 Gothenburg, Sweden.; Department of Radiology, Sahlgrenska University Hospital, 41345 Gothenburg, Sweden.; Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, 41390 Gothenburg, Sweden., Visuttijai K; Department of Clinical Pathology, Sahlgrenska University Hospital, 41345 Gothenburg, Sweden.; Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, 41390 Gothenburg, Sweden., Vukusic K; Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, 41390 Gothenburg, Sweden., Sandstedt J; Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, 41390 Gothenburg, Sweden.; Department of Clinical Chemistry, Sahlgrenska University Hospital, 41345 Gothenburg, Sweden., Sandstedt M; Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, 41390 Gothenburg, Sweden.; Department of Clinical Chemistry, Sahlgrenska University Hospital, 41345 Gothenburg, Sweden., Bobbio E; Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, 41390 Gothenburg, Sweden.; Department of Cardiology, Sahlgrenska University Hospital, 41345 Gothenburg, Sweden., Björkenstam M; Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, 41390 Gothenburg, Sweden.; Department of Cardiology, Sahlgrenska University Hospital, 41345 Gothenburg, Sweden., Karason K; Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, 41390 Gothenburg, Sweden.; Department of Cardiology, Sahlgrenska University Hospital, 41345 Gothenburg, Sweden.; Department of Transplantation, Sahlgrenska University Hospital, 41345 Gothenburg, Sweden., Bergh N; Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, 41390 Gothenburg, Sweden.; Department of Cardiology, Sahlgrenska University Hospital, 41345 Gothenburg, Sweden., Bollano E; Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, 41390 Gothenburg, Sweden.; Department of Cardiology, Sahlgrenska University Hospital, 41345 Gothenburg, Sweden., Oldfors A; Department of Clinical Pathology, Sahlgrenska University Hospital, 41345 Gothenburg, Sweden.; Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, 41390 Gothenburg, Sweden.

Publikováno v: Diagnostics (Basel, Switzerland) [Diagnostics (Basel)] 2024 Oct 24; Vol. 14 (21). Date of Electronic Publication: 2024 Oct 24.

Clinical Examples of the Additive Value of Absolute Quantification of Cell-Free DNA After Heart Transplantation.

Autor: Böhmer J; Pediatric Heart Center, The Queen Silvia Children's Hospital, Sahlgrenska University Hospital, Gothenburg, Sweden.; Department of Pediatrics, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.; Department of Pediatrics, Clinic Frankfurt-Höchst, Frankfurt, Germany., Wåhlander H; Pediatric Heart Center, The Queen Silvia Children's Hospital, Sahlgrenska University Hospital, Gothenburg, Sweden.; Department of Pediatrics, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden., Karason K; Transplant Institute, Sahlgrenska University Hospital, Gothenburg, Sweden., Sunnegårdh J; Pediatric Heart Center, The Queen Silvia Children's Hospital, Sahlgrenska University Hospital, Gothenburg, Sweden.; Department of Pediatrics, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden., Wasslavik C; Department of Clinical Chemistry, Sahlgrenska University Hospital, Gothenburg, Sweden., Jonsson M; Department of Clinical Chemistry, Sahlgrenska University Hospital, Gothenburg, Sweden., Asp J; Department of Clinical Chemistry, Sahlgrenska University Hospital, Gothenburg, Sweden.; Department of Laboratory Medicine, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden., Ricksten A; Department of Clinical Chemistry, Sahlgrenska University Hospital, Gothenburg, Sweden.; Department of Laboratory Medicine, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden., Dellgren G; Transplant Institute, Sahlgrenska University Hospital, Gothenburg, Sweden.; Department of Cardiothoracic Surgery, Sahlgrenska University Hospital, Gothenburg, Sweden.; Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.

Publikováno v: Clinical transplantation [Clin Transplant] 2024 Oct; Vol. 38 (10), pp. e15477.

Malignancies After Heart Transplantation.

Autor: Stenman C; Transplant Institute, Sahlgrenska University Hospital, Gothenburg, Sweden., Wallinder A; Transplant Institute, Sahlgrenska University Hospital, Gothenburg, Sweden.; Department of Cardiothoracic Surgery, Sahlgrenska University Hospital, Gothenburg, Sweden., Holmberg E; Regional Cancer Center West, Region Västra Götaland, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.; Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden., Karason K; Transplant Institute, Sahlgrenska University Hospital, Gothenburg, Sweden.; Department of Cardiology, Sahlgrenska University Hospital, Gothenburg, Sweden.; Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden., Magnusson J; Transplant Institute, Sahlgrenska University Hospital, Gothenburg, Sweden.; Department of Internal Medicine/Respiratory Medicine and Allergology, Sahlgrenska University Hospital, Gothenburg, Sweden.; Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden., Dellgren G; Transplant Institute, Sahlgrenska University Hospital, Gothenburg, Sweden.; Department of Cardiothoracic Surgery, Sahlgrenska University Hospital, Gothenburg, Sweden.; Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.

Publikováno v: Transplant international : official journal of the European Society for Organ Transplantation [Transpl Int] 2024 Sep 09; Vol. 37, pp. 12109. Date of Electronic Publication: 2024 Sep 09 (Print Publication: 2024).

Long-term follow-up of the randomized, prospective Scandinavian heart transplant everolimus de novo study with early calcineurin inhibitors avoidance (SCHEDULE) trial.

Autor: Bollano E; Department of Cardiology, Sahlgrenska University Hospital, Gothenburg, Sweden; Department of Transplantation, Sahlgrenska University Hospital, Gothenburg, Sweden; Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden. Electronic address: entela.bollano@vgregion.se., Andreassen AK; Department of Cardiology, Oslo University Hospital Rikshospitalet, Oslo, Norway., Eiskjaer H; Department of Cardiology, Aarhus University Hospital, Aarhus, Denmark., Gustafsson F; Department of Cardiology, Rigshospitalet, Copenhagen, Denmark; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark., Rådegran G; Section for Heart Failure and Valvular Disease, Skåne University Hospital and Department of Clinical Sciences, Cardiology, Lund University, Lund, Sweden., Gude E; Department of Cardiology, Oslo University Hospital Rikshospitalet, Oslo, Norway., Gullestad L; Department of Cardiology, Oslo University Hospital Rikshospitalet, Oslo, Norway; KG Jebsen Center for Cardiac Research, University of Oslo, Oslo, Norway., Broch K; Department of Cardiology, Oslo University Hospital Rikshospitalet, Oslo, Norway; KG Jebsen Center for Cardiac Research, University of Oslo, Oslo, Norway., Halden TAS; Department of Immunology, Novartis Norge AS, Oslo, Norway., Karason K; Department of Transplantation, Sahlgrenska University Hospital, Gothenburg, Sweden; Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden., Bartfay SE; Department of Cardiology, Sahlgrenska University Hospital, Gothenburg, Sweden; Department of Transplantation, Sahlgrenska University Hospital, Gothenburg, Sweden; Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden., Bergh N; Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.

Publikováno v: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation [J Heart Lung Transplant] 2024 Dec; Vol. 43 (12), pp. 1948-1959. Date of Electronic Publication: 2024 Jul 20.

Mortality in relation to diabetes remission in Swedish Obese Subjects -a prospective cohort study.

Autor: Carlsson LMS; Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden., Carlsson B; Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.; Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Jacobson P; Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden., Karlsson C; Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.; Late-Stage Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Andersson-Assarsson JC; Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden., Kristensson FM; Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.; Region Västra Götaland, Sahlgrenska University Hospital/Östra, Dept of Surgery, Gothenburg, Sweden., Ahlin S; Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.; Region Västra Götaland, NU hospital group, Department of Clinical Physiology, Trollhättan, Sweden., Svensson PA; Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.; Institute of Health and Care Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden., Taube M; Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden., Näslund I; Department of Surgery, Faculty of Medicine and Health, Örebro University, Örebro, Sweden., Karason K; Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden., Peltonen M; Finnish Institute for Health and Welfare, Helsinki, Finland., Sjöholm K; Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.

Publikováno v: International journal of surgery (London, England) [Int J Surg] 2024 Jun 19. Date of Electronic Publication: 2024 Jun 19.